ALX Oncology Holdings Inc. (ALXO) has a MoatMap StockRank of 21/100 based on Quality (21/100), Value (36/100), and Momentum (55/100) factor scores. The current signal is SELL. ALX Oncology Holdings Inc (US, Healthcare) has a very low Q score (21). As a small-cap biotech/healthcare company, it likely represents a high-risk venture without the established quality, durable moat, or clear macro tailwind required for a high-conviction investment.